Sionna Therapeutics (NASDAQ:SION) Drops 92% After Failed Study, Shares Fall Below Gross Cash
WALTHAM, Massachusetts, August 10, 2026, 12:00 EDT — Sionna Therapeutics fell 92% after its study missed its main goal, sending the stock below the company's reported gross cash position.
